{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:55:27Z","timestamp":1784336127143,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.annder.2010.08.011","type":"journal-article","created":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T05:21:31Z","timestamp":1285737691000},"page":"782-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Caract\u00e9ristiques cliniques et \u00e9volutives du scl\u00e9romyx\u0153d\u00e8me\u00a0: \u00e9tude r\u00e9trospective multicentrique"],"prefix":"10.1016","volume":"137","author":[{"given":"M.","family":"Le Moigne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mazereeuw-Hautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Bonnetblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Astudillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"D\u2019Incan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bessis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Debarbieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ammoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Lamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2010.08.011_bib0005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1067\/mjd.2001.111630","article-title":"Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema","volume":"44","author":"Rongioletti","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0010","unstructured":"Saurat JH, Lachapelle JM, Lipsker D, Thomas L. Dermatologie et infections sexuellement transmissibles. Paris: Masson; 2008. p.\u00a0581\u20135."},{"key":"10.1016\/j.annder.2010.08.011_bib0015","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000096914","article-title":"Scleromyxedema: successful treatment with thalidomide in two patients","volume":"214","author":"Amini-Adle","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2010.08.011_bib0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1365-2230.2008.02744.x","article-title":"Scleromyxoedema with associated peripheral neuropathy: successful treatment with thalidomide","volume":"33","author":"Peter","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0025","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archderm.1991.01680100137029","article-title":"Regression of scleromyxedema with topical betamethasone and dimethyl sulfoxide: a 30-month follow-up","volume":"127","author":"Bonnetblanc","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0030","first-page":"38","article-title":"Mucinose papuloscl\u00e9reuse (scl\u00e9romyxoed\u00e8me) cutan\u00e9o-syst\u00e9mique. R\u00e9mission apr\u00e8s photochimioth\u00e9rapie extracorporelle et bolus de cortico\u00efdes","volume":"128","author":"D\u2019Incan","year":"2001","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2010.08.011_bib0035","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jaad.2007.04.033","volume":"57","author":"Heymann","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0040","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1183\/09031936.02.99109302","article-title":"Severe lung involvement in systemic scleromyxoedema: a highly unusual finding","volume":"19","author":"Morales","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.annder.2010.08.011_bib0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00005792-200109000-00005","article-title":"The neurologic complications of scleromyxedema","volume":"80","author":"Berger","year":"2001","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2010.08.011_bib0050","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jaad.2008.11.013","article-title":"Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin","volume":"60","author":"Rey","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00005792-198801000-00004","article-title":"Scleromyxedema: a scleroderma-like disorder with systemic manifestations","volume":"67","author":"Gabriel","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.annder.2010.08.011_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-4362.2003.01565.x","article-title":"Scleromyxedema revisited","volume":"42","author":"Pomann","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","article-title":"Scleromyxedema","volume":"33","author":"Dinneen","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0070","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1126\/science.622555","article-title":"Lichen myxedematosus serum stimulates human skin fibroblast proliferation","volume":"199","author":"Harper","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.annder.2010.08.011_bib0075","first-page":"837","article-title":"Scleromyxedema serum increases proliferation but not the glycosaminoglycan synthesis of dermal fibroblasts","volume":"16","author":"Ferrarini","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0080","first-page":"549","article-title":"Scleromyxedema","volume":"24","author":"Chanda","year":"1979","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2010.08.011_bib0085","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0190-9622(98)70567-5","article-title":"Fatal scleromyxedema: report of a case and review of the literature","volume":"38","author":"Godby","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0090","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2340\/00015555-0731","article-title":"Vincristine, idarubicin, dexamethasone and thalidomide in scleromyxoedema","volume":"89","author":"Laimer","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2010.08.011_bib0095","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaad.2004.01.058","article-title":"Treatment of recalcitrant scleromyxedema with thalidomide in 3\u00a0patients","volume":"51","author":"Sansbury","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1001\/archderm.140.3.277","article-title":"Thalidomide as a potential treatment for scleromyxedema","volume":"140","author":"Caradonna","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0105","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/j.1468-3083.2006.01761.x","article-title":"Successful treatment of scleromyxedema using thalidomide","volume":"20","author":"Thyssen","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2010.08.011_bib0110","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000093856","article-title":"Scleromyxedema, a positive effect with thalidomide","volume":"213","author":"Jacob","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2010.08.011_bib0115","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/bmt.2008.148","article-title":"Complete and durable remission in a patient with life-threatening scleromyxedema treated with high-dose melphalan and BU with auto-SCT","volume":"42","author":"Cheng","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.annder.2010.08.011_bib0120","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1001\/archderm.141.10.1277","article-title":"Successful treatment of scleromyxedema with autologous peripheral blood stem cell transplantation","volume":"141","author":"Lacy","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1182\/blood-2004-12-4870","article-title":"Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation","volume":"107","author":"Donato","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.annder.2010.08.011_bib0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.semarthrit.2007.10.015","article-title":"Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature","volume":"38","author":"Efthimiou","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.annder.2010.08.011_bib0135","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00105-001-0298-4","article-title":"Initial scleromyxedema. Successful treatment with melphalan","volume":"53","author":"Schubert","year":"2002","journal-title":"Hautarzt"},{"key":"10.1016\/j.annder.2010.08.011_bib0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archderm.1969.01610190057010","article-title":"Scleromyxedema. A dramatic response to melphalan","volume":"99","author":"Feldman","year":"1969","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0145","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1610-0387.2003.t01-1-02502.x","article-title":"Treatment of scleromyxedema with hydroxychloroquine","volume":"1","author":"Terheyden","year":"2003","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.annder.2010.08.011_bib0150","first-page":"277","article-title":"Scleromyxedema: immunosuppressive therapy with cyclophosphamide","volume":"39","author":"Aberer","year":"1988","journal-title":"Hautarzt"},{"key":"10.1016\/j.annder.2010.08.011_bib0155","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/0378-6323.13787","article-title":"Successful treatment of scleromyxedema with dexamethasone cyclophosphamide pulse therapy","volume":"71","author":"Kuldeep","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.annder.2010.08.011_bib0160","first-page":"89","article-title":"Scleromyxedema: successful treatment of cutaneous and neurologic symptoms","volume":"65","author":"Nieves","year":"2000","journal-title":"Cutis"},{"key":"10.1016\/j.annder.2010.08.011_bib0165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0190-9622(96)90650-7","article-title":"Treatment of scleromyxedema with 2-chlorodeoxyadenosine","volume":"35","author":"Davis","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0170","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0190-9622(88)70199-1","article-title":"Scleromyxedema: therapeutic response to isotretinoin in three patients","volume":"19","author":"Milam","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0175","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/0190-9622(91)70132-L","article-title":"Improvement of scleromyxedema associated with isotretinoin therapy","volume":"24","author":"Hisler","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0180","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0190-9622(08)81176-0","article-title":"Successful treatment of scleromyxedema with plasmapheresis and immunosuppression","volume":"22","author":"Keong","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0185","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archderm.1987.01660300108022","article-title":"Plasmapheresis in a patient with scleromyxedema","volume":"123","author":"Westheim","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0190","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0190-9622(99)70471-8","article-title":"Scleromyxedema: treatment with interferon alfa","volume":"40","author":"Tschen","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2010.08.011_bib0195","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2133.1982.tb04539.x","article-title":"Electron-beam treatment of scleromyxoedema","volume":"106","author":"Lowe","year":"1982","journal-title":"Br J Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963810003613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963810003613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:56:56Z","timestamp":1758970616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963810003613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0151963810003613"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2010.08.011","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caract\u00e9ristiques cliniques et \u00e9volutives du scl\u00e9romyx\u0153d\u00e8me\u00a0: \u00e9tude r\u00e9trospective multicentrique","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2010.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}